Angry Gamers Bomb Game Reviewer

Schedule I faces a copyright infringement claim, but the accuser's own games are now the target of a fan-driven review bombing campaign. Learn more about the accusation and what's next for Schedule I's development.

Schedule I Latest News

Studio Accusing Schedule I of Copyright Infringement Hit by Steam Review Bombing

The indie crime simulator Schedule I has been accused of copyright infringement by Movie Games S.A., the studio behind The Drug Dealer Simulator series. As reported by the Polish Press Agency on April 3, the company completed a legal review and concluded that Schedule I may have infringed on its intellectual property. Their analysis suggests similarities in plot, gameplay mechanics, and user interface.

Although no official findings have been released, the gaming community has quickly taken sides, with support leaning heavily toward Schedule I. In response, The Drug Dealer Simulator and its sequel have been flooded with negative Steam reviews, now marked as "Overwhelmingly Negative" and "Mostly Negative," respectively.

Recent critical reviews accuse Movie Games S.A. of bullying a smaller developer and acting hypocritically, noting that other similar games existed before without facing legal action. This backlash persists despite the series previously being praised by both critics and fans as a standout in the crime management genre.

Schedule I is a cooperative crime sim where players begin as low-level dealers and climb the ranks to become underworld leaders. Since its Early Access launch on PC on March 25, it has earned "Overwhelmingly Positive" reviews on Steam. Currently ranked as the platform's second top-selling title, it has outperformed popular games like inZOI, Monster Hunter Wilds, and the indie title R.E.P.O. According to SteamDB, Schedule I reached an all-time peak of 459,075 concurrent players.

At Game8, we found Schedule I to be a surprisingly engaging and satisfying experience, essentially a "Breaking Bad" simulator. For our full early access impressions, read our detailed coverage below.